Technology Transfer of O-(2-[18F] Fluoroethyl)-L-Tyrosine (IASOglio<sup>®</sup>) Radiopharmaceutical

Technology Transfer of O-(2-[18F] Fluoroethyl)-L-Tyrosine (IASOglio<sup>®</sup>) Radiopharmaceutical

<b>Background/Objectives</b>: Gliomas, including the most aggressive subtype—glioblastoma multiforme, are brain tumors with an unfavorable prognosis and high mortality. Early diagnosis is essential to improve treatment efficacy. Positron emission tomography PET with O-(2-[<sup>18&l...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Notaro, Salvatore Limpido, Lucie Plougastel, Alessandro Zega, Mauro Telleschi, Mauro Quaglierini, Alessia Danti, Antonio Fiore, Letizia Guiducci, Michela Poli
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Pharmaceuticals
Subjects:
radiopharmaceuticals
glioma
[<sup>18</sup>F]FET
GMP
technology transfer
Online Access:https://www.mdpi.com/1424-8247/18/6/769
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/18/6/769

Similar Items